CAS Number: 70359-46-5
EC Number: 629-848-5
Molecular Weight: 442.22
Chemical Formula: C₁₅H₁₆BrN₅O₆
IUPAC Name: 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine;(2R,3R)-2,3-dihydroxybutanedioic acid
Purity: Conforme aux limites pharmacopéiques (USP/EP/BP) ; teneur non inférieure à 98,0 % par HPLC (base anhydre, sans solvant)
Titre (Assay): 98,0–102,0 % sur base anhydre/séchée (titrage ou HPLC, selon la monographie pharmacopéique)
Profil d'impuretés: Conforme aux seuils ICH Q3A(R2)/Q3B(R2) pour l'identification, la qualification et le signalement des impuretés individuelles et totales

Autres informations

Description supplémentaire:

Filings include US-DMF, CEP, C-DMF, K-DMF, and CADIFA, under submission or approval. C2 Pharma supplies a broad range of active pharmaceutical ingredients and complex chemical compounds from synthetic and natural sources, including brimonidine tartrate. As a 0.2% ophthalmic solution, brimonidine lowers intraocular pressure through a dual mechanism - reducing aqueous humour production by the ciliary body and increasing uveoscleral outflow - while, applied topically as a 0.33% gel, it treats persistent (non-transient) erythema associated with rosacea.